PMC:7425568 / 1422-1912 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T3","span":{"begin":467,"end":471},"obj":"Body_part"}],"attributes":[{"id":"A3","pred":"fma_id","subj":"T3","obj":"http://purl.org/sig/ont/fma/fma7154"}],"text":"uman pathogen until late 2019. With information continuing to accumulate, early clinical and management strategies do not reflect many current guidelines. Also, there is continued disagreement among experts regarding the future trajectory of the virus, with some predicting consistent infection and mortality numbers as others are sharing more hopeful predictions. The first reports of possible mutations and decreases in potency came from Dr. Alberto Zangrillo, the head of intensive care "}

{"project":"LitCovid-PD-UBERON","denotations":[{"id":"T3","span":{"begin":467,"end":471},"obj":"Body_part"}],"attributes":[{"id":"A3","pred":"uberon_id","subj":"T3","obj":"http://purl.obolibrary.org/obo/UBERON_0000033"}],"text":"uman pathogen until late 2019. With information continuing to accumulate, early clinical and management strategies do not reflect many current guidelines. Also, there is continued disagreement among experts regarding the future trajectory of the virus, with some predicting consistent infection and mortality numbers as others are sharing more hopeful predictions. The first reports of possible mutations and decreases in potency came from Dr. Alberto Zangrillo, the head of intensive care "}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T5","span":{"begin":285,"end":294},"obj":"Disease"}],"attributes":[{"id":"A5","pred":"mondo_id","subj":"T5","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"}],"text":"uman pathogen until late 2019. With information continuing to accumulate, early clinical and management strategies do not reflect many current guidelines. Also, there is continued disagreement among experts regarding the future trajectory of the virus, with some predicting consistent infection and mortality numbers as others are sharing more hopeful predictions. The first reports of possible mutations and decreases in potency came from Dr. Alberto Zangrillo, the head of intensive care "}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T10","span":{"begin":246,"end":251},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_10239"},{"id":"T11","span":{"begin":467,"end":471},"obj":"http://purl.obolibrary.org/obo/UBERON_0000033"},{"id":"T12","span":{"begin":467,"end":471},"obj":"http://www.ebi.ac.uk/efo/EFO_0000964"}],"text":"uman pathogen until late 2019. With information continuing to accumulate, early clinical and management strategies do not reflect many current guidelines. Also, there is continued disagreement among experts regarding the future trajectory of the virus, with some predicting consistent infection and mortality numbers as others are sharing more hopeful predictions. The first reports of possible mutations and decreases in potency came from Dr. Alberto Zangrillo, the head of intensive care "}

{"project":"LitCovid-sentences","denotations":[{"id":"T12","span":{"begin":31,"end":154},"obj":"Sentence"},{"id":"T13","span":{"begin":155,"end":364},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"uman pathogen until late 2019. With information continuing to accumulate, early clinical and management strategies do not reflect many current guidelines. Also, there is continued disagreement among experts regarding the future trajectory of the virus, with some predicting consistent infection and mortality numbers as others are sharing more hopeful predictions. The first reports of possible mutations and decreases in potency came from Dr. Alberto Zangrillo, the head of intensive care "}

{"project":"LitCovid-PubTator","denotations":[{"id":"30","span":{"begin":285,"end":294},"obj":"Disease"},{"id":"31","span":{"begin":299,"end":308},"obj":"Disease"}],"attributes":[{"id":"A30","pred":"tao:has_database_id","subj":"30","obj":"MESH:D007239"},{"id":"A31","pred":"tao:has_database_id","subj":"31","obj":"MESH:D003643"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"uman pathogen until late 2019. With information continuing to accumulate, early clinical and management strategies do not reflect many current guidelines. Also, there is continued disagreement among experts regarding the future trajectory of the virus, with some predicting consistent infection and mortality numbers as others are sharing more hopeful predictions. The first reports of possible mutations and decreases in potency came from Dr. Alberto Zangrillo, the head of intensive care "}